Clinical Trial Update: Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing conventional versus hypofractionated radiotherapy with temozolomide in elderly glioblastoma patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Severance Hospital | Conditions: Glioblastoma | Phase 3 | Status: RECRUITING